Carrie A. Hughes

FDA investigator

Appears on 8 documents from 2017 to 2023, most often at sites in California. Most often cites design controls (21 CFR 820.30).

8
Documents on file
8.5
Observations per 483
2017
First seen
2023
Most recent

What they cite most

From 68 observations

Activity by year

2017: 2, 2018: 3, 2019: 1, 2020: 1, 2023: 1

Where

California 3 · India 3 · Arizona 2

Is Carrie A. Hughes coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

8 documents, newest first
FirmOpen
483 Abraxis BioScience, LLCOct 6, 2023 · Phoenix, Arizona
483 Abraxis BioScience, LLCFeb 19, 2020 · Phoenix, Arizona
483 Calyx Chemicals & Pharmaceuticals LimitedNov 8, 2019 · Boisar, India
483 B. Braun US Pharmaceutical Manufacturing LLCJun 29, 2018 · Irvine, California
483 Amneal Oncology Private LimitedMar 15, 2018 · Mahaboobnagar, India
483 Auronext Pharma A-1128, Riico Industrial Area, Phase -Mar 6, 2018 · Bhiwadi, India
483 Amphastar Pharmaceuticals, IncMar 31, 2017 · Rancho Cucamonga, California

About this profile

What does Carrie A. Hughes inspect?

Carrie A. Hughes appears on 8 documents on file covering 6 sites, most often in California.

What do they cite most often?

21 CFR 820.30 (design controls), followed by 21 CFR 211.100 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Carrie A. Hughes is dated Oct 6, 2023.